Home » MHRA, EMEA: Drugmakers Can Group Changes to Marketing Authorizations
MHRA, EMEA: Drugmakers Can Group Changes to Marketing Authorizations
December 17, 2009
Drugmakers seeking to amend a marketing authorization with the European Medicines Agency (EMEA) or the UK’s Medicines and Healthcare products Regulatory
Agency (MHRA) now can group proposed changes into a single application.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor